Literature DB >> 29071944

[Effect of Moxibustion Stimulation of "Feishu" (BL 13) and "Xinshu" (BL 15) on Expression of Myocardial MyD 88 Protein and Caspase 3 mRNA in Chronic Heart Failure Rats].

Jing Wang1, Yong-Lei Zeng2, Feng-Qin Wu3, Rui-Rui Sun3, Jing Chen3, Xue-Zhao Jia3, Yu-Hong Xi3.   

Abstract

OBJECTIVE: To observe the effect of moxibustion stimulation of "Feishu" (BL 13) and "Xinshu" (BL 15) on pathological changes of myocardium and the expression of myocardial myeloid differentiation factor 88 (MyD 88) protein and Caspase 3 mRNA in chronic heart failure (CHF) rats, so as to explore its mechanism underlying improvement of CHF.
METHODS: SD male rats were randomly divided into normal (n=9), model (n=8), moxibustion (n=8), medication (n=8) and moxibustion + medication (n=8) groups. In addition, the other 6 rats (3/normal and 3/model groups) were used for measuring cardiac ventricle weight and H.E. stain. The CHF model was made by intraperitoneal injection of Adriamycin (ADR, from 1 to 4 mg/kg, once every other day for 15 days). Mild moxibustion was applied to bilateral BL13 and BL15 for 15 min, once daily for 3 weeks. Rats of the medication group were treated by Captopril (gavage) for 3 weeks. The expression of myocardial Caspase 3 mRNA and MyD 88 protein of the left ventricle was determined by quantitative real time-PCR and Western blot, respectively.
RESULTS: In comparison with the normal group, the myocardial damage (cell swelling, cytoplasma vaculation, and disordered arrangement, rupture and lysis of some cardiac muscle fibers), and the expression levels of myocardial MyD 88 protein and Caspase 3 mRNA were obviously increased in the model group(P<0.01). After the interventions, the myocardial damage was relatively milder, and the expression of myocardial MyD 88 protein and Caspase 3 mRNA were significantly down-regulated in the moxibustion, me-dication and moxibustion+medication groups in comparison with the model group(P<0.05). No significant differences were found among the 3 treatment groups in the expression levels of MyD 88 protein and Caspase 3 mRNA(P>0.05).
CONCLUSIONS: Moxibustion intervention can suppress CHF induced up-regulation of expression of myocardial MyD 88 protein and Caspase 3 mRNA in rats, which may contribute to its effect in relieving myocardial injury.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 29071944

Source DB:  PubMed          Journal:  Zhen Ci Yan Jiu        ISSN: 1000-0607


  6 in total

1.  Efficacy of Dialectical Comprehensive Treatment of Traditional Chinese Medicine in Patients with Chronic Stable Heart Failure: A Randomized Controlled Trial.

Authors:  Lixiang Yang; Yuanyuan Chen; Fei Lou; Xiaoxia Zhao; Jia Zhou
Journal:  Cardiol Res Pract       Date:  2022-05-12       Impact factor: 1.990

2.  Moxibustion alleviates chronic heart failure by regulating mitochondrial dynamics and inhibiting autophagy.

Authors:  Ran Xia; Wei Wang; Bing Gao; Qiang Ma; Jing Wang; Xiaohua Dai; Qingling Li
Journal:  Exp Ther Med       Date:  2022-03-30       Impact factor: 2.447

Review 3.  The Effect of Acupuncture and Moxibustion on Heart Function in Heart Failure Patients: A Systematic Review and Meta-Analysis.

Authors:  Bingxue Liang; Cui Yan; Lu Zhang; Zhonqi Yang; Lingjun Wang; Shaoxiang Xian; Lu Lu
Journal:  Evid Based Complement Alternat Med       Date:  2019-10-20       Impact factor: 2.629

4.  Moxibustion Improves Chronic Heart Failure by Inhibiting Autophagy and Inflammation via Upregulation of mTOR Expression.

Authors:  Qingling Li; Wei Wang; Qiang Ma; Ran Xia; Bing Gao; Guoqi Zhu; Jing Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-02-02       Impact factor: 2.629

5.  Diagnostic Imaging Analysis and Care of Patients with Endomyocardial Fibrosis Based on Wireless Network Smart Medical Application.

Authors:  Zaomei Chen; Jingya Wen
Journal:  J Healthc Eng       Date:  2022-03-23       Impact factor: 2.682

6.  Examining the Effector Mechanisms of the Feishu Acupoint (BL13) in the Treatment of Pneumonia Based on Systematic Acupuncture and Moxibustion Research.

Authors:  Yan Xu; Jiali Cai; Weibin Li; Jingkun Miao; Yan Mei; Xinna Wang; Hanying Xu; Qixiong Chen; Fang Liu; Hongtao Cui
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-05       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.